Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F23R7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,865
Award facts
- Contract value 100% obligated
- $2,864.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,864.82 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with an ultimate completion date of November 28, 2025. This non-set-aside, firm fixed price contract represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the DLA Medical Supply Chain, supplying pharmaceutical products to support military and veteran healthcare systems. Teriparatide is a recombinant human parathyroid hormone used in osteoporosis treatment, reflecting the breadth of specialty medications encompassed within the prime vendor contract. AmerisourceBergen's competitively awarded federal contracts demonstrate its capability to manage diverse therapeutic domains and deliver medical commodities ranging from brand-name and generic medications to specialized medical supplies, supporting Defense Health Agency and broader government healthcare system requirements worldwide.
Quick answers
Who was awarded contract SPE2DR26F23R7?
SPE2DR26F23R7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F23R7 worth?
The government has obligated $2,865 on SPE2DR26F23R7.
Is contract SPE2DR26F23R7 an order under another contract?
Yes. SPE2DR26F23R7 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F23R7 competed?
The extent of competition for SPE2DR26F23R7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award